Implementation of the Human Papillomavirus (HPV) Vaccination Program to Enhance Primary Prevention of Cervical Cancer among the Academic Community and the Public at the Faculty of Medicine, Mitra Bunda Institute of Health Sciences
DOI:
https://doi.org/10.55927/jpmb.v5i8.58Keywords:
Human Papillomavirus, HPV Vaccination, Cervical Cancer, Primary Prevention, Community Service.Abstract
Human Papillomavirus (HPV) infection is a primary cause of cervical cancer, which remains a significant public health issue in Indonesia. Primary prevention efforts through HPV vaccination need to be continuously enhanced by engaging educational institutions as partners in health promotion. The activity was conducted from February 6–8, 2026, at the Faculty of Medicine, Mitra Bunda Health Institute, Batam, comprising stages of registration, health screening, education, vaccination, and observation for Adverse Events Following Immunization (AEFI). The target audience included students, the academic community, and the general public. A total of 400 participants registered, and 338 successfully received the HPV vaccine; no severe AEFIs were reported during the event. This program demonstrates that collaboration between educational institutions and healthcare professionals can support increased vaccination coverage and strengthen primary prevention efforts against cervical cancer through integrated education and healthcare services.
References
Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J., Gómez, D., Muñoz, J., Bosch, F., & de Sanjosé, S. (2023). Human Papillomavirus and Related Diseases in the World. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre).
Bruni, L., Saura-Lázaro, A., Montoliu, A., Brotons, M., Alemany, L., Diallo, M. S., Afsar, O. Z., LaMontagne, D. S., Mosina, L., Contreras, M., Velandia-González, M., Pastore, R., Gacic-Dobo, M., & Bloem, P. (2021). HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010–2019. Preventive Medicine, 144, 106399. https://doi.org/10.1016/j.ypmed.2020.106399
Centers for Disease Control and Prevention. (2024). Human Papillomavirus (HPV). https://www.cdc.gov/hpv/
Drolet, M., Bénard, É., Pérez, N., Brisson, M., Ali, H., Boily, M. C., Baldo, V., Brassard, P., Brotherton, J. M. L., Callander, D., Checchi, M., Chow, E. P. F., Cocchio, S., Dalianis, T., Deeks, S. L., Dehlendorff, C., Donovan, B., Fairley, C. K., Flagg, E. W., … Yu, B. N. (2019). Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: Updated systematic review and meta-analysis. The Lancet, 394(10197), 497–509. https://doi.org/10.1016/S0140-6736(19)30298-3
International Agency for Research on Cancer. (2024). Global Cancer Observatory: Indonesia Fact Sheet. https://gco.iarc.who.int/en
Kementerian Kesehatan Republik Indonesia. (2023). Profil Kesehatan Indonesia 2023. https://kemkes.go.id/id/profil-kesehatan-indonesia-2023
Sushil Kumar, S. V. A., Manash Biswas, B., & Jose, T. (2015). HPV vaccine: Current status and future directions. Medical Journal, Armed Forces India, 71(2), 171–174. https://doi.org/10.1016/j.mjafi.2015.02.006
World Health Organization. (2020). Global strategy to accelerate the elimination of cervical cancer as a public health problem. World Health Organization. https://www.who.int/publications/i/item/9789240014107
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Sri Tati Rukiyani, Ditte Ayu Suntara, Dandy Citra, Tonny Yulianto, Yuli Mariany, Yanuarni Wulandari Baji Pamai, Sindy Nurafia, Rundito, Irbath Hamdanie, Farras Arlinda Rachmawati
This work is licensed under a Creative Commons Attribution 4.0 International License.
